The long-term objective of our research is to understand the mechanisms by which obesity, and specifically upper body obesity (UBO), causes insulin resistance and the other health problems such as Type 2 Diabetes. Our focus is on the release of free fatty acids (FFA) from adipose tissue lipolysis in humans and how those FFA affect the functioning of other tissues (lipotoxicity).
The specific aims of this proposal are to: 1) Determine whether impaired insulin-induced suppression of lipolysis (as measured by IC50) is related to the above mentioned lipolysis proteins in groups of volunteers known to vary widely with regards to abdominal adipocyte size and regulation of adipose tissue lipolysis; 2) Determine whether the improved insulin regulation of lipolysis resulting from treatment with the PPAR? agonist pioglitazone, with or without weight loss, can be linked to specific changes in sets of PPAR?-responsive adipocyte lipolysis proteins in UBO adults; 3) Determine whether the adipose inflammatory cell and cytokine content in Class III obesity is related to lipolysis insulin resistance and, if so, whether sustained, substantial weight loss one year following bariatric surgery reduces inflammation in parallel with improved insulin regulation of lipolysis. We will measure of insulin- regulated adipose tissue lipolysis in vivo and assess adipocyte lipolysis proteins, inflammation and insulin signaling in obese humans with widely varying degrees of insulin resistance. Our hypothesis is that proteins involved in the final steps of the regulation of lipolysis are altered in humans with large fat cells, and that these alterations are responsible for adipose insulin resistance. Combined, we believe these studies will offer insights as to why adipose tissue lipolysis is abnormal in some obesity phenotypes and provide information on what therapeutic strategies to treat adipose insulin resistance are most compelling.
We wish to understand why people who gain weight primarily in the abdominal area are more prone to illnesses such as diabetes. We know that fat tissue under the skin in the abdominal area releases excess fat release into the bloodstream, which then effects how the rest of our body is able to metabolize sugars. The experiments we propose will measure whether certain proteins in fat cells are present in abnormal amounts and whether this alters the ability of fat cells to respond to the body's signals that are supposed to reduce the release of fats into the bloodstream.
|Espinosa De Ycaza, A E; Donegan, D; Jensen, M D (2017) Long-term metabolic risk for the metabolically healthy overweight/obese phenotype. Int J Obes (Lond) :|
|Santosa, Sylvia; Bush, Nikki C; Jensen, Michael D (2017) Acute Testosterone Deficiency Alters Adipose Tissue Fatty Acid Storage. J Clin Endocrinol Metab 102:3056-3064|
|Chung, Jin Ook; Koutsari, Christina; Blachnio-Zabielska, Agnieszka U et al. (2017) Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans. Diabetes 66:2082-2091|
|Lu, Jin; Varghese, Ron T; Zhou, Lianzhen et al. (2017) Glucose tolerance and free fatty acid metabolism in adults with variations in TCF7L2 rs7903146. Metabolism 68:55-63|
|Morgan-Bathke, Maria; Harteneck, Debra; Jaeger, Philippa et al. (2017) Comparison of Methods for Analyzing Human Adipose Tissue Macrophage Content. Obesity (Silver Spring) 25:2100-2107|
|Puig, Kendra L; Brose, Stephen A; Zhou, Xudong et al. (2017) Amyloid precursor protein modulates macrophage phenotype and diet-dependent weight gain. Sci Rep 7:43725|
|Søndergaard, Esben; Espinosa De Ycaza, Ana Elena; Morgan-Bathke, Maria et al. (2017) How to Measure Adipose Tissue Insulin Sensitivity. J Clin Endocrinol Metab 102:1193-1199|
|Anthanont, Pimjai; Levine, James A; McCrady-Spitzer, Shelly K et al. (2017) Lack of Seasonal Differences in Basal Metabolic Rate in Humans: A Cross-Sectional Study. Horm Metab Res 49:30-35|
|Anthanont, Pimjai; Jensen, Michael D (2016) Does basal metabolic rate predict weight gain? Am J Clin Nutr 104:959-963|
|Vella, Adrian; Jensen, Michael D; Nair, K Sreekumaran (2016) Eulogy for the Metabolic Clinical Investigator? Diabetes 65:2821-3|
Showing the most recent 10 out of 54 publications